Clinical trial

Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers

NCT06680856

Study summary

ClinicalTrials.gov

Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

COMBINATION_PRODUCT · Unmapped registry intervention PRP+HA Find medicine records · Find other trials using this name

COMBINATION_PRODUCT · Unmapped registry intervention HA Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-02-23

PhasePHASE1 / PHASE2

Conditions

Diabetic Foot Ulcerunresolved

Skin Lesionsunresolved

Allogeneicunresolved

PRPverified · MONDO: familial pityriasis rubra pilaris

Interventions

PRP+HACOMBINATION_PRODUCT

HACOMBINATION_PRODUCT

Sponsors & collaborators

Ospedale Policlinico San Martinolead sponsor

IRCSS Istituto Dermopatico dell'Immacolata, Fondazione Luigi Maria Monticollaborator

Universita degli Studi di Genovacollaborator

Mapped research locations

RomaItaly1 GenovaGE, Italy1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06680856 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.